| pubmed-article:11549872 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C0123257 | lld:lifeskim |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C0123707 | lld:lifeskim |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C0021665 | lld:lifeskim |
| pubmed-article:11549872 | lifeskim:mentions | umls-concept:C2347946 | lld:lifeskim |
| pubmed-article:11549872 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11549872 | pubmed:dateCreated | 2001-9-10 | lld:pubmed |
| pubmed-article:11549872 | pubmed:abstractText | Little information is available on the relevance of parameters representing the insulin-like growth factor (IGF) system with regard to growth hormone (GH) treatment during childhood. In adults, high IGF-I levels were found to be associated with side effects and long-term risks. AIM/METHOD: Our aim was to monitor the serum levels of IGF-I, IGF-binding protein (IGFBP) 3, and IGFBP-2 during long-term GH treatment of 156 patients with GH deficiency (GHD) and of 153 non-GHD patients. We determined the extent to which the IGF parameters exceed the normal ranges and identified those parameters which are predictive of 1st-year growth. | lld:pubmed |
| pubmed-article:11549872 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11549872 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11549872 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11549872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11549872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11549872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11549872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11549872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11549872 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11549872 | pubmed:issn | 0301-0163 | lld:pubmed |
| pubmed-article:11549872 | pubmed:author | pubmed-author:WeberKK | lld:pubmed |
| pubmed-article:11549872 | pubmed:author | pubmed-author:RankeM BMB | lld:pubmed |
| pubmed-article:11549872 | pubmed:author | pubmed-author:SchweizerRR | lld:pubmed |
| pubmed-article:11549872 | pubmed:author | pubmed-author:BinderGG | lld:pubmed |
| pubmed-article:11549872 | pubmed:author | pubmed-author:WollmannH AHA | lld:pubmed |
| pubmed-article:11549872 | pubmed:author | pubmed-author:ElmlingerM... | lld:pubmed |
| pubmed-article:11549872 | pubmed:author | pubmed-author:SchwarzeC PCP | lld:pubmed |
| pubmed-article:11549872 | pubmed:copyrightInfo | Copyright 2001 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:11549872 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11549872 | pubmed:volume | 55 | lld:pubmed |
| pubmed-article:11549872 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11549872 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11549872 | pubmed:pagination | 115-24 | lld:pubmed |
| pubmed-article:11549872 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:meshHeading | pubmed-meshheading:11549872... | lld:pubmed |
| pubmed-article:11549872 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11549872 | pubmed:articleTitle | Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents. | lld:pubmed |
| pubmed-article:11549872 | pubmed:affiliation | Paediatric Endocrinology Section, University Children's Hospital, Hoppe-Seyler Strasse 1, D-72076 Tübingen, Germany. mlranke@med.uni-tuebingen.de | lld:pubmed |
| pubmed-article:11549872 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11549872 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11549872 | lld:pubmed |
